TY - JOUR
T1 - Toxin-antitoxin systems in clinical pathogens
AU - Fernández-García, Laura
AU - Blasco, Lucia
AU - Lopez, Maria
AU - Bou, German
AU - García-Contreras, Rodolfo
AU - Wood, Thomas
AU - Tomas, María
N1 - Publisher Copyright:
© 2016 by the authors; licensee MDPI, Basel, Switzerland.
PY - 2016/7/20
Y1 - 2016/7/20
N2 - Toxin-antitoxin (TA) systems are prevalent in bacteria and archaea. Although not essential for normal cell growth, TA systems are implicated in multiple cellular functions associated with survival under stress conditions. Clinical strains of bacteria are currently causing major human health problems as a result of their multidrug resistance, persistence and strong pathogenicity. Here, we present a review of the TA systems described to date and their biological role in human pathogens belonging to the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) and others of clinical relevance (Escherichia coli, Burkholderia spp., Streptococcus spp. and Mycobacterium tuberculosis). Better understanding of the mechanisms of action of TA systems will enable the development of new lines of treatment for infections caused by the above-mentioned pathogens.
AB - Toxin-antitoxin (TA) systems are prevalent in bacteria and archaea. Although not essential for normal cell growth, TA systems are implicated in multiple cellular functions associated with survival under stress conditions. Clinical strains of bacteria are currently causing major human health problems as a result of their multidrug resistance, persistence and strong pathogenicity. Here, we present a review of the TA systems described to date and their biological role in human pathogens belonging to the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) and others of clinical relevance (Escherichia coli, Burkholderia spp., Streptococcus spp. and Mycobacterium tuberculosis). Better understanding of the mechanisms of action of TA systems will enable the development of new lines of treatment for infections caused by the above-mentioned pathogens.
UR - http://www.scopus.com/inward/record.url?scp=84979277026&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979277026&partnerID=8YFLogxK
U2 - 10.3390/toxins8070227
DO - 10.3390/toxins8070227
M3 - Review article
C2 - 27447671
AN - SCOPUS:84979277026
SN - 2072-6651
VL - 8
JO - Toxins
JF - Toxins
IS - 7
M1 - 227
ER -